标普和纳斯达克内在价值 联系我们

Cingulate Inc. CINGW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
32/100
1/5 Pass
SharesGrow Intrinsic Value
$2,260,930.00
+10766333233.3%

Cingulate Inc. (CINGW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

分析师预估 每股收益(EPS)为 $-9.44 和 营收为 $0.00B (下一财年).

每股收益(EPS)历史表现: 2024: 实际 $-8.80 vs 预期 $-9.44 (超预期 +6.7%). 2025: 实际 $-4.13 vs 预期 $-3.82 (不及预期 -8.1%). 分析师准确度: 93%.

EPS 预测 — CINGW

93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$8.80 vs Est –$9.44 ▲ 7.2% off
2025 Actual –$4.13 vs Est –$3.82 ▼ 7.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

营收预测 — CINGW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言